Showing results (71-80 of 221) with videos related to
Sort By:
Pageof 23
JACC. Cardiovascular Interventions|June 19, 2017
Plasma Phospholipids and Sphingolipids Identify Stent Restenosis After Percutaneous Coronary InterventionSong Cui, Kefeng Li, Lawrence Ang, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 28, 2017
Acute procedural outcomes of orbital atherectomy for the treatment of iliac artery disease: Sub-analysis of the CONFIRM registriesMichael S Lee, Brad J Martinsen, John Hollowed, et al.JACC. Cardiovascular Interventions|July 8, 2017
Demonstration of the Safety and Feasibility of Robotically Assisted Percutaneous Coronary Intervention in Complex Coronary Lesions: Results of the CORA-PCI Study (Complex Robotically Assisted Percutaneous Coronary Intervention)Ehtisham Mahmud, Jesse Naghi, Lawrence Ang, et al.Annals of Vascular Surgery|February 9, 2023
Comparing Outcomes of Transfemoral Versus Transbrachial or Transradial Approach in Carotid Artery Stenting (CAS)Maryam Ali Khan, Taiwo S Dodo-Williams, Claire Janssen, et al.Journal of the Society for Cardiovascular Angiography & Interventions|January 14, 2025
Peak Procedural ACT Is Associated With All-Cause Mortality After Femoral Access PCIRevathy Sampath-Kumar, Ori Ben-Yehuda, Belal Al Khiami, et al.Journal of the American College of Cardiology|July 31, 2012
Pre-hospital electrocardiography by emergency medical personnel: effects on scene and transport times for chest pain and ST-segment elevation myocardial infarction patientsMitul Patel, James V Dunford, Steve Aguilar, et al.Medical Devices (Auckland, N.Z.)|July 16, 2016
New developments in the clinical use of drug-coated balloon catheters in peripheral arterial diseaseJesse Naghi, Ethan A Yalvac, Ali Pourdjabbar, et al.Thrombosis Research|March 28, 2006
Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) studyAlex Malinin, Alex Pokov, Malcolm Spergling, et al.Journal of the American Heart Association|November 20, 2017
Elevated Baseline Serum Fibrinogen: Effect on 2-Year Major Adverse Cardiovascular Events Following Percutaneous Coronary InterventionLawrence Ang, Omid Behnamfar, Samhita Palakodeti, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 10, 2017
Robotically-assisted percutaneous coronary intervention: Reasons for partial manual assistance or manual conversionJonathan Harrison, Lawrence Ang, Jesse Naghi, et al.Pageof 23